The Role of Twinning Programs and Telemedicine in Pediatric Oncology

  • Valentino ConterEmail author
  • Roberto Polillo
  • Erica Brivio
  • Agostino Faravelli
  • Giuseppe Masera


Childhood cancer survival rates in highly developed countries have risen remarkably over the past 50 years from <10 % to over 80 %. This has been achieved as a result of early and precise diagnosis, effective and targeted treatment, and adequate supportive care. This contrasts with the situation in low- and middle-income countries (LMICs) where overall survival rates are <20 %. In order to address this gross inequity and improve chances of survival of children with cancer, a number of twinning programs, linking pediatric oncology units in resource-rich countries with units in countries with limited resources, have been established.


Pediatric Oncology Internet Connection Pediatric Oncology Group Telemedicine Application Online Service Provider 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We would like to thank the following for their contribution to the project “La Mascota”: Fondazione CARIPLO, Comitato Maria Letizia Verga, Fondazione Tettamanti, Fondazione Zegna, AMCA (Bellinzona, Switzerland), CONANCA and MAPANICA (Nicaragua), the HMJR “La Mascota” Hospital (Managua), St. Jude Children’s Research Hospital (SJCRH, Memphis, USA), and the Pediatric Oncology Group of Ontario (POGO).


  1. 1.
    Wilimas JA, Ribeiro RC. Pediatric hematology-oncology outreach for developing countries. Hematol Oncol Clin North Am. 2001;15(4):775–87, x.Google Scholar
  2. 2.
    Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL, Ribeiro RC. Childhood cancer epidemiology in low-income countries. Cancer. 2008;112(3):461–72.PubMedCrossRefGoogle Scholar
  3. 3.
    Magrath I, et al. Pediatric oncology in less developed countries. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott; 1993. p. 1225–51.Google Scholar
  4. 4.
    Ribeiro RC, Pui CH. Saving the children–improving childhood cancer treatment in developing countries. N Engl J Med. 2005;352(21):2158–60.PubMedCrossRefGoogle Scholar
  5. 5.
    Kellie SJ, Howard SC. Global child health priorities: what role for paediatric oncologists? Eur J Cancer. 2008;44:2388–96.PubMedCrossRefGoogle Scholar
  6. 6.
    Wagner HP, Antic V. The problem of pediatric malignancies in the developing world. Ann N Y Acad Sci. 1997;824:193–204.PubMedCrossRefGoogle Scholar
  7. 7.
    Masera G, Baez F, Biondi A, et al. Bridging the childhood cancer mortality gap between economically developed and low income countries: lessons from the MISPHO experience. In: Tannenberg S, Cavalli F, Pannuti F, editors. Cancer in developing countries. The great challenge for oncology in the 21st century. Muenchen: Zuckschwerdt; 2004. p. 42–60.Google Scholar
  8. 8.
    Wagner H. Alliances in pediatric oncology: where do we go from here? Med Pediatr Oncol. 2001;36(2):310–1.PubMedCrossRefGoogle Scholar
  9. 9.
    The Montevideo Document. SIOP News. 1997;17:32.Google Scholar
  10. 10.
    Baez F, Ocampo E, Conter V, et al. Treatment of childhood Hodgkin’s disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol. 1997;8:247–50.PubMedCrossRefGoogle Scholar
  11. 11.
    Baez F, Pillon M, Manfredini L, et al. Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua. Pediatr Blood Cancer. 2008;50:148–52.PubMedCrossRefGoogle Scholar
  12. 12.
    Baez F, Fossati Bellani F, Ocampo E, et al. Treatment of childhood Wilms’ tumor without radiotherapy in Nicaragua. Ann Oncol. 2002;13:944–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Masera G, Baez Lacayo F, Malta Corea A, et al. Pediatric oncology in developing countries: a cooperative program in Nicaragua. Ann Oncol. 1993;4:37–40.PubMedCrossRefGoogle Scholar
  14. 14.
    SIOP. 43rd Congress of the International Society of Paediatric Oncology (SIOP) 2011, Auckland, New Zealand, 28th–30th October 2011. Abstracts Pediatr Blood Cancer. 2011;57(5):705–897. doi: 10.1002/pbc.23299.
  15. 15.
    Masera G, Baez F, et al. North–south twinning in paediatric haemato-oncology: the La Mascota programme, Nicaragua. Lancet. 1998;352(9144):1923–6.PubMedCrossRefGoogle Scholar
  16. 16.
    D’Angio GJ. The La Mascota project. J Pediatr Hematol Oncol. 2009;31(10):709.PubMedCrossRefGoogle Scholar
  17. 17.
    Masera G. Bridging the childhood cancer mortality gap between economically developed and low-income countries. J Pediatr Hematol Oncol. 2009;31(10):710–2.PubMedCrossRefGoogle Scholar
  18. 18.
    Edefonti A, Montini G, Castellon M; for the Nicaraguan Network of Pediatric Nephrology—NINEPEN. Comprehensive cooperative project for children with renal disease in Nicaragua. Clin Nephrol. 2010;74 Suppl. 1:S119–25.Google Scholar
  19. 19.
    Sala A, Barr RD, Masera G, MISPHO Consortium. A survey of resources and activities in the MISPHO family of institutions in Latin America: a comparison of two eras. Pediatr Blood Cancer. 2004;43(7):758–64.PubMedCrossRefGoogle Scholar
  20. 20.
    Howard SC, Marinoni M, Castillo L, Bonilla M, Tognoni G, Luna-Fineman S, Antillon F, Valsecchi MG, Pui CH, Ribeiro RC, Sala A, Barr RD, Masera G, MISPHO Consortium Writing Committee. Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer. 2007;48(3):364–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Howard SC, Ortiz R, Baez LF, Cabanas R, Barrantes J, Fu L, Peña A, Samudio A, Vizcaino M, Rodríguez-Galindo C, Barr RD, Conter V, Biondi A, Masera G, MISPHO Consortium Writing Committee. Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)—part I. Pediatr Blood Cancer. 2007;48(4):486–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Valsecchi MG, Tognoni G, Bonilla M, Moreno N, Baez F, Pacheco C, Hernandez AP, Antillon-Klussmann F, Machin S, Cabanas R, Navarrete M, Nieves R, De Lorenzo P, Masera G, Monza’s International School of Paediatric Hematology-Oncology. Clinical epidemiology of childhood cancer in Central America and Caribbean countries. Ann Oncol. 2004;15(4):680–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Rohatiner A. Keynote comment: not just an exercise in solidarity. Lancet Oncol. 2005;6(11):818–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Antillon F, Baez FL, Barr R, Barrantes Zamorra JC, Carrasco LF, Moreno B, Bonilla MM, Tognoni G, Valsecch MG, Howard S, Ribeiro RC, Masera G. AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediatr Blood Cancer. 2005;45(2):107–10.PubMedCrossRefGoogle Scholar
  25. 25.
    Quintana Y, Nambayan A, Ribeiro R, et al. Cure4Kids—building online learning and collaboration networks. AMIA Annu Symp Proc. 2003;2003:978.Google Scholar
  26. 26.
    Israëls T, Chirambo C, Caron H, de Kraker J, Molyneux E, Reis R. The guardians’ perspective on paediatric cancer treatment in Malawi and factors affecting adherence. Pediatr Blood Cancer. 2008;51:639–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Hesseling PB, Broadhead R, Molyneux E, Borgstein E, Schneider JW, Louw M, Mansvelt EP, Wessels G. Malawi pilot study of Burkitt lymphoma treatment. Med Pediatr Oncol. 2003;41:532–40.PubMedCrossRefGoogle Scholar
  28. 28.
    Mostert S, Sitaresmi M, Gundy C. PK020 influence of socioeconomic status on childhood acute lymphoblastic leukaemia treatment in Indonesia [abstract]. Pediatr Blood Cancer. 2006;47:489.Google Scholar
  29. 29.
    Hunger SP, Sung L, Howard SC. Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: a proposal. Pediatr Blood Cancer. 2009;52(5):559–65. doi: 10.1002/pbc.21889.PubMedCrossRefGoogle Scholar
  30. 30.
    Arora RS, Eden T, Pizer B. The problem of treatment abandonment in children from developing countries with cancer. Pediatr Blood Cancer. 2007;49(7):941–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Sitaresmi MN, Mostert S, Schook RM, Sutaryo, Veerman AJ. Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences. Psychooncology. 2010;19(4):361–7. doi: 10.1002/pon.1578.PubMedCrossRefGoogle Scholar
  32. 32.
    Spinetta JJ, Masera G, Eden T, et al. Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer: a report of the SIOP Working Committee on Psychosocial Issues in Paediatric Oncology. Med Pediatr Oncol. 2002;38:114–7.PubMedCrossRefGoogle Scholar
  33. 33.
    World Health Organization, Telemedicine: opportunities and developments in member states; report on the Second Survey on eHealth, 2010 (Global Observatory for eHealth Series 2). Available from
  34. 34.
    ITU. Measuring the information society; 2012. Available from
  35. 35.
    Bellina L, Missoni E. Mobile cell-phones (M-phones) in telemicroscopy: increasing connectivity of isolated laboratories. Diagn Pathol. 2009;4:19.PubMedCrossRefGoogle Scholar
  36. 36.
    Bellina L, Missoni E. M-learning: mobile phones’ appropriateness and potential for the training of laboratory technicians in limited-resource settings. Health Technol. 2011;1:93–97Google Scholar
  37. 37.
  38. 38.
  39. 39.
  40. 40.
  41. 41.
  42. 42.

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Valentino Conter
    • 1
    • 2
    Email author
  • Roberto Polillo
    • 3
  • Erica Brivio
    • 1
  • Agostino Faravelli
    • 4
  • Giuseppe Masera
    • 1
  1. 1.Pediatric Department, Ospedale San GerardoUniversity of Milano Bicocca—Fondazione MBBMMonzaItaly
  2. 2.International Outreach Program, St. Jude Children’s Research HospitalMemphisUSA
  3. 3.DISCO Department of Informatics, Systems and CommunicationUniversity of Milano BicoccaMilanItaly
  4. 4.Surgical PathologyPatologi Oltre Frontiera, DesioMilanItaly

Personalised recommendations